论文部分内容阅读
目的探讨肝癌手术切除加肝动脉置泵化疗对肝癌的治疗价值。方法对64例肝癌患者行肝癌切除或姑息切除加肝动脉置泵,药盒置于皮下,术后第7天重复给药1次,以后每21天重复给药1次,共计4～6次,经泵反复给药化疗。结果围术期死亡1例;生存期:1、3、5年生存率分别为69.1%、44.6%、27.5%。结论肝癌手术切除加肝动脉置泵化疗在治疗肝癌中,肝动脉置泵操作简单,并发症及手术风险较少,术后给药方便,减少了患者全身化疗的痛苦,肿瘤复发时间延长,患者生活质量得到改善。
Objective To investigate the therapeutic value of hepatectomy and hepatic artery pump chemotherapy on liver cancer. Methods Sixty-four patients with hepatocellular carcinoma underwent hepatectomy or palliative resection plus hepatic artery pump. The kit was placed subcutaneously. The drug was repeatedly administered once on the 7th day after operation and once every 21 days for a total of 4 to 6 times , Repeatedly administered by pump chemotherapy. Results Perioperative death in 1 case; survival: 1, 3, 5-year survival rates were 69.1%, 44.6%, 27.5%. Conclusion Hepatic cancer resection plus hepatic artery pump chemotherapy in the treatment of liver cancer, hepatic artery pump operation is simple, less complications and less surgical risk, convenient administration after surgery, reducing the patient’s systemic chemotherapy pain, tumor recurrence time, patients The quality of life is improved.